Affordable Access

Publisher Website

Prevalence and Risk of Thrombophilia Defects in Vascular Patients

Elsevier Ltd
Publication Date
DOI: 10.1016/j.ejvs.2004.03.027
  • Thrombophilia
  • Peripheral Arterial Disease And Risk
  • Medicine


Abstract This paper reviews the available data on the prevalence of thrombophilia defects in patients with peripheral vascular disease (PVD) and attempts to delineate the risk of failure of vascular intervention in these patients. The prevalence of thrombophilia in stable claudicants is 25% and increases to 40% in those requiring revascularisation, compared to only 11% in the control group. The overall prevalence of thrombophilia defects in patients with premature atherosclerosis appears to be between 15 and 30%. The prevalence in the typical cohort of patients with PVD appears to be similar. All these studies have recruited patients with symptoms significant enough to warrant intervention. The overall prevalence of thrombophilia calculated from these trials, therefore, may not be truly indicative of the general vascular population who may not even present primary or secondary healthcare. The risk of thrombotic occlusion following arterial revascularisation in patients with an identified thrombophilia defect appears to be almost three times that of patients with no evidence of a thrombophilia defect. The best management of these patients has not been determined and needs to be evaluated by prospective randomized trials.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Prevalence and risk of thrombophilia defects in va...

on European Journal of Vascular a... August 2004

The prevalence of thrombophilia in patients with s...

on The British journal of surgery May 2006

Defects in the prostaglandin-system--heredity, pre...

on Prostaglandins, leukotrienes,... July 1990

Defects in the prostaglandin-system — Heredity, pr...

on Prostaglandins Leukotrienes an... Jan 01, 1990
More articles like this..